LEARNING OBJECTIVES
At the end of this program, participants will be able to:
• Analyze the data from the PARTNER 2A and SAPIEN 3 trials and understand the similarities
• Evaluate the importance of the new data and how it applies to current and future use of TAVR
• Discuss the role of TAVR and SAVR in different patient populations and the patient outcomes
CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
TARGET AUDIENCE
This activity is designed for interventional cardiologists, cardiac surgeons, clinical cardiologists, vascular medicine specialists, and other healthcare professionals.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
FACULTY DISCLOSURE SUMMARY
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E) Equity (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
Howard Herrmann: (G/R) Abbott Vascular, Boston Scientific, Medtronic, St. Jude Medical, (G/R) (C/H/S) Edwards Lifesciences, (C/H/S) (E) Microinterventional Devices
Martin B. Leon: (G/R) Abbott Vascular, Boston Scientific Corporation, Edwards Lifesciences, Medtronic, St. Jude Medical, (C/H/S) Abbott Vascular, Boston Scientific Corporation, (E) Claret Medical, Cathworks Ltd., Elixir, GDS, Medinol, Mitralign, Valve MD
Craig Smith: (O) Edwards Lifesciences
Vinod Thourani: (G/R) Boston Scientific, Claret Medical, St. Jude Medical (G/R) (C/H/S) Abbott Vascular, Edwards Lifesciences, Medtronic
Planning Committee
Arielle Gelardi (Planner)
(S) Cardiovascular Research Foundation
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation. It is supported through an educational grant from Edwards LifeSciences and was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Arielle Gelardi at agelardi@crf.org .